Free shipping on all orders over $ 500

GS967

Cat. No. M8911
GS967 Structure
Synonym:

GS-458967

Size Price Availability Quantity
10mg USD 200 In stock
50mg USD 700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

GS967 (GS-458967) is a highly selective late sodium channel current blocker.

In vitro: GS967 (10, 100, 300 nM) completely attenuates the effect of ATX-II (10 nM) to increase action potential duration (APD) and APD variability in ventricular myocytes, with an apparent IC50 value of ∼10 nM and decreased the beat-to-beat variability of APD.

In vivo: GS967 causes a reduction of INaP in a frequency-dependent manner, consistent with use-dependent block (UDB). GS967 evokes more potent UDB of INaP (IC50=0.07 μM) than ranolazine (16 μM) and lidocaine (17 μM). GS967 is found to exert these same effects on a prototypical long QT syndromemutation (delKPQ). GS967 prevents ischemia-induced increases in alternans in the left atrium and left ventricle. GS967 reduces ischemia-induced increases in depolarization heterogeneity and repolarizationheterogeneity.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 347.22
Formula C14H7F6N3O
CAS Number 1262618-39-2
Purity >98%
Solubility DMSO 40 mg/mL
Ethanol 40 mg/mL
Storage at -20°C
References

Use-Dependent Block of Human Cardiac Sodium Channels by GS967.
Potet F, et al. Mol Pharmacol. 2016 Jul;90(1):52-60. PMID: 27136942.

Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity.
Bonatti R, et al. Heart Rhythm. 2014 Oct;11(10):1827-35. PMID: 24953379.

A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L, et al. J Pharmacol Exp Ther. 2013 Jan;344(1):23-32. PMID: 23010360.

Related Sodium Channel Products
GNE-131

GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC50 of 3 nM.

PF-06869206

PF-06869206 is an orally bioavailable selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1) with an IC50 of 380 nM.

Eleclazine hydrochloride

Eleclazine HCl is a novel late Na+ current inhibitor, with IC50 value of 0.7 uM.

Levobupivacaine

Levobupivacaine is a reversible neuronal sodium channel inhibitor.

PF-05089771

PF-05089771 is a selective Nav1.7 channel blocker that interacts with the voltage-sensor domain (VSD) of domain IV.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: GS967, GS-458967 supplier, Sodium Channel, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.